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Abstract
Background: Bovine viral diarrhea virus (BVDV) types 1 and 2 are members of the Pestivirus genus of the Flaviviridae
family. This genus also includes the HoBi-like virus, tentatively classified as BVDV type 3. BVDV-1 is widely distributed in
Italy despite the extensive use of BVDV-1-based vaccines, while BVDV-2 and HoBi-like Pestivirus have been detected
occasionally. Monitoring the occurrence of sporadic or atypical pestiviruses is a useful approach to evaluate the need
for additional vaccine strains that can be used in BVDV control programs.
Results: In this study we developed a multiwell antibody ELISA based on the recombinant E2 protein of the three bovine
pestiviruses. We evaluated the assay’s applicability for surveillance purposes using pooled milk samples, each prepared
from a maximum of 35 lactating cows and collected from 176 dairy herds. As expected, the majority of the
pooled samples reacted to a greater extent against the BVDV-1 E2 antigen. All three milk pools from a single
farm reacted to the BVDV-2 antigen, however. Further analysis using spot tests, antigen detection, and sequence analysis
of the 5′-UTR region confirmed the presence of five persistently infected calves carrying a BVDV-2a strain.
Conclusions: This study highlights for the first time that sporadic circulation of BVDV-2 can be predicted by
immunoenzymatic methods in the absence of specific vaccination.
Keywords: Bvdv-1, Bvdv-2, HoBi-like Pestivirus, E2 glycoprotein, Bulk milk ELISA
Background
Bovine viral diarrhea virus (BVDV) types 1 and 2 belong
to the Pestivirus genus of the Flaviviridae family, along
with border disease virus (BDV) and classical swine
disease virus [1]. Other atypical pestiviruses include
HoBi-like virus, tentatively classified as BVDV type 3 [2,
3], and wild ungulate pestiviruses. The severity of
clinical signs is strictly associated with the viral strain
and the type of infection. In most cattle infected transi-
ently with BVDV, disease signs are mild, characterized
by low-grade fever, diarrhea, and coughing [1, 4].
Infection is sustained by persistently infected (PI)
carriers that acquire the infection with a non cytopathic
(NCP) strain early in the fetal stage and remain immu-
notollerant virus shedders for life. The lifespan of PI ani-
mals is usually short due to early culling or the
development of mucosal disease (MD), a fatal outcome
arising from mutation of the NCP strain to its cytopathic
(CP) counterpart.
The distribution of BVD virus types and subtypes is
continuously evaluated in some European countries. A
well-established procedure of sequencing the 5’UTR
viral fragment from PI animals has been widely used,
allowing characterization of the circulating viral strains
[5]. BVDV-1 is detected with higher frequency than
BVDV-2, but BVDV-2 outbreaks have been frequently
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associated with severe acute disease [6–8]. Up to 17
BVDV-1 subtypes have been detected in Italy over the
course of the last 18 years despite the regular use of
BVDV-1 vaccines for nearly two decades. The hypothesis
is that some of the newly described subtypes may escape
control through herd immunity [9]. In contrast, BVDV-2
is only partially neutralized by BVDV-1-induced immun-
ity and has seldom been identified [7, 10].
Circulation of unusual or atypical pestiviruses has been
linked to iatrogenic transmission, including the prepar-
ation of vaccines contaminated by NCP strain of BVDV
type 2 [11]. The origin of the infection has not been
clearly established in some recent reports, for example,
the single outbreak of HoBi-like Pestivirus in southern
Italy [3]. Circulation of BVDV strains that may either
not or only partially be covered by vaccine-induced herd
immunity raises major concerns [12], since the impact
of infection is expected to be similar to that of a naïve
population. In this light, monitoring of possible intro-
duction of BVDV-2 and HoBi-like Pestivirus could
provide a valuable tool to assess the effectiveness of
BVDV-1-based vaccination programs and prevent the
spread of viral strains. Unfortunately, genetic classifica-
tion of BVDV strains in the course of PI identification is
not routinely carried out by diagnostic laboratories, and
analysis of BVDV isolates is often obtained years after
the identification of PI animals, limiting investigation
into risk factors for the introduction of such strains.
To our knowledge, the only serological diagnostic tool
that can differentiate BVDV infections is the cross-
seroneutralization test [13]. The E2 glycoprotein is the
most divergent antigen between BVDV type 1, 2, and
HoBi-like pestivirus and it is able to elicit neutralizing
antibodies [14, 15]. Accordingly, we developed a multiwell
antibody ELISA based on the E2 protein of the aforemen-
tioned viruses and evaluated, using pooled milk samples
collected from dairy herds, the test’s applicability for sur-
veillance purposes. A background of BVDV-1 infection
and/or immunization clearly emerged, with greater re-
activity against the BVDV-2 antigen noted in a single dairy
herd. Further investigation using spot tests (sample of ani-
mals of a certain age [16]), individual milk samples, and
antigen/RNA detection allowed the identification of
several PI animals harboring the BVDV-2a subtype.
Results
Sheep immunized with the inactivated whole virus prepar-
ation of BVDV type 1, 2, and HoBi-like pestivirus devel-
oped a strong immunoresponse against E2 viral
glycoprotein (average of homologous virus-neutralization
[VN] titers ranged from 445 to 2702). The homologous
VN titer was at least three times greater than the heterol-
ogous VN titer (Table 1). The three control sera were nor-
malized by diluting the two most reactive sera into
negative bovine serum to attain a homologous VN titer
equal to the less reactive serum. Checkerboard titration
was performed to evaluate antigen expression levels. The
results showed a large difference in ELISA reactivity, lead-
ing to the assumption that expression levels differed
widely, with BVDV type 1 E2 being 100 times more react-
ive than the HoBi-like one. BVDV-1 antigen was diluted
to 1:900, BVDV-2 to 1:150, and Hobi-like to 1:8. Any at-
tempt to improve the signal of the latter antigen, including
the use of a baculovirus expression system, has been
unsuccessful so far (data not shown).
In order to better evaluate the test performances, a set
of 51 negative sera from 8 different farms was used to
estimate the cut-off of acceptance (OD cut-off 0.5). In
the other hand, sera collected from animals (bovine or
rabbits) transiently infected or immunized with a defined
BVDV strain were tested and found to be more reactive
versus homologous BVDV antigen, although some were
raised in response to different clades within the same
viral species (Fig. 1). This sample set allowed us to set a
discrimination cut-off at 1.42, representing the ratio
between reactivity against the homologous and the
heterologous antigens.
Sera from immunized sheep always reacted to a greater
extent against the E2 protein corresponding to the hom-
ologous immunogen (Additional file 1: Figure S1) when
used as positive controls in 17 test runs (i.e., ELISA
plates). Based on the 17 ELISA runs, each control showed
significantly higher reactivity against the homologous anti-
gen as compared to the highest heterologous antigens. For
each positive control serum, reactivity against the homolo-
gous antigen was compared to the highest OD obtained
when the serum was tested against the heterologous anti-
gens. The Wilcoxon signed rank test showed significant
differences (p < 0.001 in all three cases), with the median
ratio higher than 1.42 in all three (BVDV1 6.55, BVDV2
5.76, BVDV3 2.25).
The method was then applied to a total of 436 milk pools
collected from 179 dairy farms: the number of pools per
farm ranged between 1 and 9. On the basis of the proposed
method of classification, 33 farms showed only negative
Table 1 Cross-neutralization titer induced in sheep by inactivated
preparation of BVDV-1, BVDV-2, and HoBi-like Pestivirus, based on 5
independent replicates. Range of titers is reported within brackets
SN titers
Serum Against BVDV-1 Against BVDV-2 Against HoBi-
like
#8135 BVDV-1
immunized
1782.89
[1024–2048]
48.50
[32–64]
97.01
[64–128]
#9750 BVDV-2
immunized
1.74
[0–2]
445.72
[256–512]
27.86
[16–32]
#8148 HoBi-like
immunized
97.01
[64–128]
776.05
[512–1024]
2702.35
[2048–4096]
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pools (n = 125). Further investigation revealed that no vac-
cination programs were in place on any of the farms during
sample collection. A total of 111 pools, from 63 farms,
showed the greatest reactivity against the BVDV type 1
antigen. A few milk pools from 3 farms reacted against
BVDV-2 antigen. In particular, 3 pools from a single farm
showed clear reactivity on E2 ELISA (Fig. 2a). Questioning
farmers about their animal management practices revealed
that a double-strain live vaccine, based on BVDV-1 and 2
strains, was used on the remaining 2 farms. Fourteen pools
showed reactivity against HoBi-like pestivirus just above
the level of discrimination (data not shown). The BVDV
type could not be ascertained in 177 pools.
The farm with clear BVDV-2 reactivity was further in-
vestigated. Testing of individual young animals that had
never been vaccinated confirmed that most were reactive
against the type 2 antigen (Fig. 2b). Five PI animals were
identified in this group. Sequences of the 5′-UTR region
obtained from two of the animals were 100% similar;
based on the similarity found between the newly obtained
sequence and the sequences available in GenBank data-
base and the tree topology, the analyses confirmed that
the animals carried the BVDV-2a strain (GenBank acces-
sion number KU878975, Fig. 3). No PI animals were found
among lactating cows.
Discussion
Circulation of BVDV-2 in Italy was occasionally docu-
mented between 1995 and 2004 [17, 18]. Its genetic
characterization accounts for less than 3% of the total
Fig. 1 Dispersion plot of ELISA reactivity using sera from animals transiently infected or immunized with a BVDV-1 (panel a), BVDV-2 (panel b), and
HOBI-like strain (panel c). Circles: bovine sera; triangles: rabbit sera; squares: bovine sera from experimentally infected animals. Reactivity
against homologous antigen (Y axis) and the most reactive heterologous antigen (X axis) are shown. Dashed lines represent equal reactivity;
dotted lines represent cut-off discrimination
Fig. 2 Dispersion plot of ELISA reactivity versus BVDV-1 recombinant E2 (Y axis) and BVDV-2 recombinant E2 (X axis). Diagonal and envelope lines
represent equal reactivity and cut-off discrimination, respectively. Panel a: Reactivity of pooled milk samples. Strain specific control sera are shown
as white triangles. White dots denote pool milk samples reactive against BVDV-1 antigen. Grey dots denote indeterminate samples. Black dots denote
pools from a single dairy farm reactive against BVDV-2 antigen. Panel b: Spot test on young animals. Grey dots denote negative or indeterminate samples.
Black dots denote individual serum samples reactive against BVDV-2 antigen. Black squares denote individual serum samples from a BVDV-1 positive farm
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pestivirus sequences retrieved from the literature. Due
to its high sensitivity, RT-PCR has become a cost-
effective diagnostic tool for PI identification that is
applicable to pooled blood/milk samples. Sequence
analyses of positive samples represent an additional cost,
which is why they are rarely performed, thus limiting
strain characterization at the time of diagnosis. The only
genetic information available in many countries comes
from periodical screening of stored PCR positive sam-
ples. In all cases, atypical or sporadic strains have been
detected following PI identification. To our knowledge,
this is the first immunoenzymatic assay that can differ-
entiate BVDV species based on seroreactivity against the
most variable E2 glycoprotein. The ELISA format was
successfully employed on both serum samples and indi-
vidual or pooled milk samples, demonstrating its use as
a cost effective tool for rapid screening of dairy herds.
Since pestiviruses display considerable heterogeneity
within one species, we first analyzed a panel of sera
raised against defined BVDV-1 and BVDV-2 strains and
then evaluated the ability of each of the E2 antigens to
specifically recognize homologous infection (at the
Fig. 3 Bayesian phylogenetic tree. New taxa obtained in this study are given in bold. Posterior probability of each node is given above the branches
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species level). The results clearly suggest that discrimin-
ation is possible even for sera raised against BVDV
species of different subtypes.
It should be noted that the proposed method has been
roughly validated for sensitivity, specificity, and discrimin-
ation power. A recent study reported that the frequency
of detection of BVDV-2 and HoBi-like viruses among 371
UTR sequences was 2.7% and 0%, respectively [19]. The
identification of a single BVDV-2 positive herd in the
present study is in line with a sporadic level of circulation.
On the other hand, a large part of the milk pools reacted
against the BVDV-1 antigen, supporting the high fre-
quency of detection of BVDV-1. Because the E2 protein
elicits neutralizing antibodies, the E2-based ELISA is
unable to discriminate between vaccinated and infected
animals. In this context, the greater reactivity against the
type 1 antigen may also reflect the extensive use of
BVDV-1 vaccination. Since a double-strain live vaccine
based on BVDV-1 and 2 strains has recently been ap-
proved for the Italian market, its use may further limit the
future usefulness of the proposed method for surveillance
purposes. The milk pools from two farms where double-
strain vaccination had been recently implemented were, in
fact, slightly more reactive against the BVDV-2 antigen.
Any attempt to identify circulating BVDV was unsuccess-
ful. However, we cannot exclude that a proportion of inde-
terminate results (shown as grey circles in Fig. 2) may
reflect the outcome of mixed seroconversion against both
a BVDV-1-based vaccine and a BVDV-2 wild-type strain
or against a double-strain based vaccine.
In this scenario, circulation of BVDV-1, 2, or HoBi-like
Pestivirus may be predicted by spot tests on young, unvac-
cinated animals, while bulk milk ELISA may serve as a
marker for herd immunity following vaccination. The
serological identification of the circulation of HoBi-like
Pestivirus is still free of confounding factors, since specific
vaccines are not available, and possible seroconversion
against Hobi-like antigens can be caused only by wild type
viral strains. Unfortunately, the HoBi-like E2 antigen was
expressed at very low levels as compared to its BVDV-1
and BVDV-2 counterparts. The lower reactivity of the
strain specific HoBi-like control serum against the homolo-
gous antigen (median OD 0.75), compared to BVDV-1 and
BVDV-2 control sera (median OD 1.5 against E2 BVDV-1
and E2 BVDV-2 antigens, respectively), as well as its lower
discriminating power (supplementary material S1), was
probably due to a lower level of expression of the trans-
fected cells. Furthermore, we cannot exclude that the lower
dilution factor (1:6) of the HoBi-like antigen during the
plate coating step might also have influenced ELISA per-
formance. For this reason, we considered as undetermined
the 14 pools weakly reacting against HoBi-like antigen; this
result may reflect unspecific reactivity against cellular pro-
teins rather than against the E2 antigen (data not shown).
Sequence analysis of BVDV-2 strains isolated from PI
animals belonging to the same herd indicated that the
strains were all subtype 2a. This subtype was identified
in northern Italy more than 20 years ago [7]. It is diffi-
cult at this stage to speculate how low levels of circula-
tion in the absence of specific vaccination could have
persisted for such a long time. The partial sequence
clustered together with strains identified in the United
States [20], falling into the BVDV-2a.1 clade. Unfortu-
nately, a clear picture of the distribution and the genetic
heterogeneity of BVDV-2 is not available. For this
reason, we can merely hypothesize that a recent intro-
duction through biological material and/or animal trade
could be responsible for the presence of the BVDV strain
identified. Extensive animal trading with European coun-
tries (mainly France and Germany) in the last 3 years
was recorded for this herd, further supporting the role
of this risk factor in the introduction of unusual
Pestiviruses. It is noteworthy that the herd has been re-
peatedly vaccinated with the BVDV-1-based inactivated
vaccine, so that antibody reactivity of lactating cows
against the homologous E2 glycoprotein could be
expected. Though vaccination may represent a bias
when interpreting the data, outbreaks of infection with
different BVDV species have occurred, given the strong
immune response the infected animals developed,
especially under the infective pressure of the PI animals.
Conclusions
This study provides evidence for how serological surveil-
lance of BVDV can provide a valuable tool for the
prompt identification of atypical Pestivirus. Serological
screening to differentiate BVDV infections can be used
for monitoring the introduction and circulation of differ-
ent Pestivirus species. Moreover, serological investigation
is a very easy way to follow and control vaccination
protocols, especially if different BVDV species are used
as the vaccine strain. This approach can improve the
surveillance system and help identify possible risk factors
associated with atypical BVDV infections.
Methods
Viruses and cells
The BVDV-1 NADL (courtesy of Dr. Ferrari, Istituto
Zooprofilattico Sperimentale di Lombardia ed. Emilia
Romagna, Brescia, Italy), BVDV-2232/02 [17], and HoBi-
like Pestivirus Italy-83/10cp [21] cytopathogenic strains
were used for immunization procedures (as inactivated
preparations) and for the virus neutralization (VN)
assays to assess the VN titer in immunized animals. All
viruses were propagated in pestivirus-free Madin-Darby
bovine kidney cell lines (MDBK; ATCC CCL-22), cul-
tured in Dulbecco’s modified essential medium (DMEM)
(Sigma-Aldrich, Schnelldorf, Germany) containing 10%
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fetal bovine serum (FBS, Gibco, Thermo Scientific,
Rodano, Italy, tested negative for pestivirus or anti-
BVDV antibody), 2 mM of L-glutamine, 100 IU/ml of
penicillin (Sigma-Aldrich), 100 mg/ml of streptomycin
(Sigma-Aldrich), and 2.5 mg/ml of amphotericin B. Cells
were incubated at 37 °C with 5% CO2. Human embryo
kidney cell lines (HEK293T; ATCC, CRL-1573) were
cultured following the same procedure and used for
transfection experiments.
For immunization, viral suspensions were inactivated
with 0.05% β-propiolactone and emulsified initially with
Tween-80 (4.1% v/v) and then with a mixture (50% v/v) of
Montanide ISA 563 (Seppic Inc., Paris, France), Marcol 52
(Esso Italiana S.r.l., Rome, Italy), and Montane 80 (Seppic
Inc.) in a 30:63:7 ratio, as previously described [22].
Strain specific sera
To obtain strain-specific control sera in the ELISA proced-
ure, three female, Biellese breed sheep were selected from
the Pestivirus-free flock belonging to the Veterinary Teach-
ing Hospital at the Department of Veterinary Science,
University of Torino. The animals were immunized with
the inactivated preparations described above. Each sheep
received two inoculations of 2 ml administered 28 days
apart. All the animals were housed at the Veterinary
Teaching Hospital under standard husbandry conditions.
The blood was drawn on day 42 after anesthesia followed
by euthanasia. Experiments were carried out at the Veter-
inary Teaching Hospital laboratories and in compliance
with the relevant national legislation on experimental
animals and animal welfare (Italian Ministry of Health DL
116/92), upon authorization by the competent authority
(Italian Ministry of Health Aut Req 26,062,013). Virus
neutralization (VN) titer against homologous and heterol-
ogous immunogens was determined for each serum by
cross-seroneutralization (5 technical replicates for each
serum). Sera were collected and freeze-dried in 5-ml
aliquots for long-term storage.
BVDV negative samples were collected from 8 BVDV-
free farms for setting the acceptance cut-off. All the
samples showed negative results when tested with a
commercial IDEXX Ab ELISA test. In addition, sera col-
lected from animals transiently infected with a defined
BVDV strain were retrieved from previous studies. The
sample set included 44 sera from 3 BVDV-1b positive
farms, 30 sera from a BVDV-2a positive farm, 6 sera
from a BVDV2c experimental infection (CODA-CERVA,
Belgium), and 4 sera from a BVDV-3 positive farm [2].
To take into account the considerable heterogeneity even
within one species, such as BVDV 1, sera from rabbits im-
munized with different members of the clade (BVDV1b, d,
g, h, and e) were kindly provided by Gian Mario Demia
(Istituto Zooprofilattico Sperimentale di Umbria e Marche,
Perugia, Italy). Strain-specific sera were used to identify the
best parameters for interpretation of the results.
Gene fragment, cloning and eukaryotic expression
Amino acid sequences, corresponding to the ectodomain
of the E2 protein of BVDV-1 (strain NADL), BVDV-2
(strain 1373), and HoBi-like Pestivirus (Italy-83/10cp) were
retrieved from the GenBank database (accession number
CAB91847, AAD38683 and AFL65619.1). Synthetic genes
(Eurofins MWG, Ebersberg Germany) were constructed
carrying HindIII and XhoI restriction sites to facilitate uni-
directional cloning. Genes were subcloned into pSecTag2/
Hygro plasmids (Invitrogen, Waltham, MA, USA), allow-
ing the extracellular sorting and secretion in the medium
of transiently transfected mammalian cells. These plasmids
were used to transform chemically competent Escherichia
coli (strain BL21) by heat shock. Ampicillin-resistant
colonies were subjected to PCR for rapid screening and
sequencing to confirm the authenticity and in-frame inser-
tion of each fragment. Endotoxin-free plasmid purification
from 500 ml of LB culture was carried out using Nucleo-
Bond® Xtra Midi/Midi Plus (Macherey-Nagel, Düren,
Germany). Sub-confluent human embryonic kidney
(HEK293T) cells, cultured in 75-cm2 flasks, were trans-
fected with 9 μg of plasmid and 21 μl of LTX transfection
reagent (Thermo Fisher Scientific, Waltham, MA, USA) in
6 ml of DMEM [23]. After 6 h at 37 °C with 5% CO2, the
transfection medium was replaced with 6 ml of protein-
free medium (ExCell293, Sigma-Aldrich) and the flasks
were incubated as described above for an additional 42 h.
The medium was then collected, centrifuged at 5000 g for
10 min to remove cell debris, and stored at −80 °C until
use. The amino acid sequences of the three E2 proteins
used in the present study are shown in Fig. 4.
Farms, milk and serum samples
During a previous study on infectious bovine rhinotrachei-
tis, milk samples were collected from 179 dairy farms lo-
cated in the Province of Cuneo, Piedmont, in collaboration
with the Regional Farmers’ Association (Associazione
Regionale Allevatori, ARA). Written consent of the milk
collection for research purposes for was obtained from all
farmers. During that study, individual milk samples were
collected from each farm, forming a total of 436 milk pool
samples from about 35 lactating animals. The same sam-
ples were used for the present work. At the time of sample
collection, the BVDV status and vaccination programs for
the dairy farms were unknown.
Following milk testing, we performed additional
testing on one of the farms that had displayed greater re-
activity against the E2 antigen of BVDV-2. Individual
blood and milk samples were collected from young
unvaccinated animals and lactating cows, respectively,
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and further analyzed by spot test (5–10 individual tests
per group) and for PI identification [16].
ELISA procedure
All control sera were normalized to a dilution corre-
sponding to a VN titer of 430. Due to the different levels
of expression of the three E2 proteins, the optimal dilu-
tion of each antigen was carried out using control sera
by checkerboard titration. Antigens were diluted in
0.1 M carbonate/bicarbonate buffer, pH 9.6, and used to
coat Nunc Maxisorp plate wells overnight at 4 °C.
After blocking non-specific sites, the milk or serum
samples were assayed undiluted or diluted 1/20 in PBS
1.25% casein, respectively. Samples were incubated for
1 h (blood serum and controls) or 2 h (milk) at room
temperature. After washing, peroxidase labeled protein
G, diluted to 10 ng/ml in PBS 1.25% casein, was added
to the wells and the plates were incubated for 45 min at
room temperature. After the final wash, the reaction was
developed with 3,3′,5,5′-tetramethylbenzidine (TMB)
and stopped with 0.2 M H2SO4. Reactivity of the mono-
specific control sera against the three antigens was eval-
uated in 10 independent tests and classified depending
on the immunogen (supplementary material S1).
Negative sera (n = 28) were from animals coming from a
not vaccinated farm where all the animals resulted negative
to official diagnostic tests. All the samples were tested
against the three antigens, and the cut-off for considering
unknown sera as positive (i.e., valuable for viral typing) was
identified as the mean reactivity plus five standard devia-
tions (mean reactivity 0.145, standard deviation 0.058).
Samples showing reactivity ≥ 0.5 (corresponding to a VN
titer between 8 and 16) were investigated for further typing.
Sera collected from animals transiently infected or im-
munized with a defined BVDV strain were then tested
against the three antigens. The sample set included 44 sera
from 3 BVDV-1b positive farms, 30 sera from a BVDV-2a
positive farm, 6 sera from animals experimentally infected
with BVDV2c strain, and 4 sera from a BVDV-3 positive
farm. We applied a BVDV typing method to analyze the
data. The ratio between the homologous antigen and the
most reactive heterologous antigen was calculated for each
sample. The distribution of ratios was evaluated (Shapiro-
Wilk test for normality assumption) and the mean minus 1
standard deviation was considered as the discrimination
cut-off for antigen reactivity. This approach indicated that
1.42 is the most restrictive ratio for seropositivity discrim-
ination among antigens. In other words, a sample is
considered positive for a given antigen if the optical density
(OD) against that antigen is greater than 142% as
compared to the ODs obtained against the other antigen
with the highest reactivity.
PI identification
PI animals were identified using an antigen ELISA
(IDEXX BVDV Ag/Serum Plus, IDEXX, Westbrook, ME,
Fig. 4 Amino acid alignment of BVDV-1, BVDV-2 and HoBi-like E2 glycoprotein ectodomains expressed in recombinant form in the present study.
Conserved cysteine residues are given in bold. Asterisks denote identical amino acids, colons (:)conserved substitutions, and dots
(.)semi-conserved substitutions
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USA). Two of the 5 PI animals (CN10.2015.813 and
CN10.2015.821) were selected for viral strain
characterization and blood serum was collected from
both. The first animal died after developing MD during
the study, and samples from the spleen and intestinal
epithelium were collected. Tissue homogenates and
blood serum from the animal were used to isolate the
viral strain on MDBK culture. Viral RNA was extracted
from homogenized tissues and infected cell culture
supernatant using an EZ1 Virus kit v2.0 (Qiagen, Hilden,
Germany). For each sample, the 5’UTR region was ampli-
fied as previously described [5]. Amplicons were purified
using Nucleospin Gel and PCR Clean-up kit (Machery
Nagel) and directly sequenced in both directions (BMR
Genomics, Padua, Italy). Consensus sequences were
aligned to homologous reference sequences available in
the online databases (Clustal W algorithm embedded in
Geneious software ver. 9.0.2), referring to the BVDV-2
classification proposed previously [24]. Phylogenetic ana-
lysis was conducted by selecting the best evolutionary
model with jModelTest version 2.1.7 [25] and applying
the Bayesian heuristic search approach included in
MrBayes software [26].
Additional file
Additional file 1: Figure S1. Reactivity of monospecific sera against
the three different recombinant antigens. Optical density values are
reported on the y axis. (TIFF 81 kb)
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